Further analysis showed that among these patients, not those with primary melanoma (n = 42) (Figure 1B) but those with metastatic melanoma (n = 244) had a significant association between low CTLA4 expression and worse OS (p = 0.0001) (Figure 1C). This evidence concerns the gene CTLA4 and melanoma.